Maqbool M, Qadrie Z. Letter to the Editor: 100-day window: Reframing early follow-up and parental guidance in recurrent wheezing. World J Clin Pediatr 2026; 15(2): 117381 [DOI: 10.5409/wjcp.v15.i2.117381]
Corresponding Author of This Article
Mudasir Maqbool, PhD, Researcher, Department of Pharmacology, Government Medical College, Kanthbagh Baramulla, Baramula 193101, Jammu and Kashmīr, India. bhatmudasir92@gmail.com
Research Domain of This Article
Pediatrics
Article-Type of This Article
Correspondence
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Jun 9, 2026 (publication date) through May 16, 2026
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Clinical Pediatrics
ISSN
2219-2808
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Maqbool M, Qadrie Z. Letter to the Editor: 100-day window: Reframing early follow-up and parental guidance in recurrent wheezing. World J Clin Pediatr 2026; 15(2): 117381 [DOI: 10.5409/wjcp.v15.i2.117381]
World J Clin Pediatr. Jun 9, 2026; 15(2): 117381 Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.117381
Letter to the Editor: 100-day window: Reframing early follow-up and parental guidance in recurrent wheezing
Mudasir Maqbool, Zulfkar Qadrie
Mudasir Maqbool, Zulfkar Qadrie, Department of Pharmacology, Government Medical College, Baramula 193101, Jammu and Kashmīr, India
Co-first authors: Mudasir Maqbool and Zulfkar Qadrie.
Author contributions: Maqbool M was the conceptual developer of the editorial and headed the critical examination of the study used and prepared the original manuscript; Qadrie Z helped in the process of interpretation of clinical implications, modulation of conceptual framework, and critical review of the manuscript to achieve significant intellectual material; both authors revised, edited and signed the final copy of the editorial and are willing to be responsible towards all the works, preparation as the co-first authors.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Mudasir Maqbool, PhD, Researcher, Department of Pharmacology, Government Medical College, Kanthbagh Baramulla, Baramula 193101, Jammu and Kashmīr, India. bhatmudasir92@gmail.com
Received: December 23, 2025 Revised: January 27, 2026 Accepted: February 13, 2026 Published online: June 9, 2026 Processing time: 158 Days and 23.3 Hours
Abstract
In paediatric treatment, persistent wheeze in babies continues to pose significant challenges for identification and management. The forthcoming retrospective cohort study recently published in World Journal of Clinical Pediatrics, entitled “Understanding recurrent wheezing: A parent’s Guide” by Kiatvitchukul et al offers essential insights by pinpointing independent factors linked to recurrence, such as age 12-24 months, preterm birth, allergic rhinitis, eosinophilia, and previous lower respiratory tract infections. The median time to recurrence of about 100 days is important since it shows that there is a good potential for quick treatment and comprehensive follow-up. This comment makes it clear how crucial it is to use this kind of proof in both community and clinical settings. By checking for clinical signs and chatting to their parents, you can find kids who are at high risk early on. This makes it easier to give them customized counselling, reduce their exposure to allergens, and start them on controller medicines when they need them. The study’s results show that pediatricians, allergists, and carers need to work together to stop the same problems from happening again and cut down on hospital readmissions. By changing how they see the “100-day window” as an important time for monitoring and putting preventive measures into action, pediatricians can improve outcomes and give families more control over their child’s respiratory health. We need more multicenter prospective research to learn more about the biological, environmental, and socioeconomic factors that lead to recurrence. This will help us turn these findings into standard approaches to care for people.
Core Tip: This study examined children hospitalized with acute lower respiratory tract infections and wheezing, identifying several independent risk factors for recurrent wheezing, including age 12-24 months, prematurity, allergic rhinitis, urban residence, eosinophilia, and prior lower respiratory tract infection. Notably, the median time to recurrence was 100 days, providing practical insight for optimizing follow-up timing and early intervention strategies.
